dehydroepiandrosterone has been researched along with Hamartoma in 3 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Hamartoma: A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of long acting GnRH agonists (GnRHa), like continuous infusion of high doses of the native peptide, results in suppression of pituitary gonadotropin secretion." | 2.37 | Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. ( Bode, HH; Boepple, PA; Crawford, JD; Crigler, JF; Crowley, WF; Mansfield, MJ; Rudlin, CR; Wierman, ME, 1986) |
| "central precocious puberty, indicating that they are controlled by independent mechanisms." | 1.28 | Lack of adrenarche in two children with precocious puberty secondary to hypothalamic hamartoma. ( Brauner, R; Rappaport, R, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rappaport, R | 1 |
| Brauner, R | 1 |
| Boepple, PA | 1 |
| Mansfield, MJ | 1 |
| Wierman, ME | 1 |
| Rudlin, CR | 1 |
| Bode, HH | 1 |
| Crigler, JF | 1 |
| Crawford, JD | 1 |
| Crowley, WF | 1 |
| Ernould, HJ | 1 |
| Thibaut, A | 1 |
| Decamps, G | 1 |
1 review available for dehydroepiandrosterone and Hamartoma
| Article | Year |
|---|---|
Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Bone Development; Child; Child, Preschool; Dehydroe | 1986 |
2 other studies available for dehydroepiandrosterone and Hamartoma
| Article | Year |
|---|---|
Lack of adrenarche in two children with precocious puberty secondary to hypothalamic hamartoma.
Topics: Adrenal Glands; Child, Preschool; Dehydroepiandrosterone; Female; Hamartoma; Hormones; Humans; Hypot | 1989 |
[Case of precocious puberty with neoplasm in the region of the mamillary bodies: treatment by interstitial radiotherapy (author's transl)].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Bone Development; Brain Neoplasms; Child; Child, Prescho | 1971 |